← New search
Phenotype profile

SARS

SaudiVarKB evidence summary derived from retained literature mentions.

273Phenotype mentions
100Publications
50Associated gene records
50Associated variant records

Associated gene records

Co-mentioned in the same publications
GeneIdentifier / contextArticlesMentions
ACE2HGNC:135572727
TLR4HGNC:1185033
CRPHGNC:236722
ABOHGNC:7922
IRF7HGNC:612222
CFHHGNC:488322
TLR8HGNC:1563222
TBK1HGNC:1158422
IFNAR2HGNC:543322
TMPRSS2HGNC:1187622
NLRP3HGNC:1640011
CDKN1AHGNC:178411
APOEHGNC:61311
HBBHGNC:482711
STAT1HGNC:1136211
MTHFRHGNC:743611
CBSHGNC:155011
LDLRHGNC:654711
ALDH1A1HGNC:40211
TP53HGNC:1199811
TFHGNC:1174011
ACEHGNC:270711
CPS1HGNC:232311
RAD51HGNC:981711
PCSK9HGNC:2000111
LZTFL1HGNC:674111
HFEHGNC:488611
BCL2L1HGNC:99211
HLA-AHGNC:493111
CUL2HGNC:255211
ELOBHGNC:1161911
ELOCHGNC:1161711
MAP7D1HGNC:2551411
PPT1HGNC:932511
RBX1HGNC:992811
THTPAHGNC:1898711
TIMM8BHGNC:1181811
ZYG11BHGNC:2582011
F5HGNC:354211
FGGHGNC:369411
CDH23HGNC:1373311
TLR3HGNC:1184911
CREBBPHGNC:234811
EP300HGNC:337311
IFNAR1HGNC:543211
CLCHGNC:201411
FGAHGNC:366111
HMGB1HGNC:498311
KPNA2HGNC:639511
TLR2HGNC:1184811

Associated variant records

Co-mentioned in the same publications
VariantIdentifier / contextArticlesMentions
D614GD614G44
L452RL452R33
E484KE484K22
N501YN501Y22
H63DH63D11
p.F8Sp.F8S11
rs16944rs1694411
K417NK417N11
rs1143634rs114363411
rs12083537rs1208353711
rs1042522rs104252211
p.His63Aspp.His63Asp11
p.Glu7Valp.Glu7Val11
Q57HQ57H11
F35GF35G11
L37FL37F11
L125FL125F11
I162TI162T11
V24AV24A11
W27LW27L11
I33TI33T11
A242VA242V11
R708WR708W11
G405EG405E11
D292ND292N11
Y633CY633C11
F308LF308L11
P323LP323L11
rs9792388rs979238811
rs3025892rs302589211
S477NS477N11
N969KN969K11
S884FS884F11
G446VG446V11
R102SR102S11
G181VG181V11
A97VA97V11
P323IP323I11
Y606CY606C11
N439KN439K11
rs4240157rs424015711
rs4343rs434311
rs11614913rs1161491311
E484QE484Q11
L452RL452R11
T478KT478K11
N501YN501Y11
rs5744080rs574408011
rs2159377rs215937711
R24CR24C11

Associated population records

Co-mentioned in the same publications
PopulationIdentifier / contextArticlesMentions
Population recordCohort 193333
Saudi Arabia1313
Population recordCohort 21111
Saudi ArabiaCohort 1955
Saudi ArabiaCohort 222
Saudi Arabia · Jeddah22
RiyadhCohort 1922
Saudi ArabiaCohort 6011
Population recordCohort 8011
Population recordCohort 511
Population recordCohort 6011
Population recordCohort 50411
Population recordCohort 15011
Population recordCohort 6311
Population recordCohort 2,01911
Population recordCohort 26111
Population recordCohort 5511
Population recordCohort 65911
Population recordCohort 17311
Saudi ArabiaCohort 4511
Saudi ArabiaCohort 611
Population recordCohort 19511
Population recordCohort 86911
Saudi Arabia · Eastern ProvinceCohort 26311
Population recordCohort 65511
Saudi ArabiaCohort 80011
Saudi Arabia · TabukCohort 1911
Population recordCohort 51511
Saudi Arabia · RiyadhCohort 14,10311
Saudi Arabia · HailCohort 26411
Saudi Arabia · RiyadhCohort 2,01911
Population recordCohort 2,24311
Population recordCohort 44511
Saudi ArabiaCohort 90011
Population recordCohort 2,15211
Population recordCohort 18111
Population recordCohort 8,00011
Saudi ArabiaCohort 42311
Population recordCohort 30111
Population recordCohort 33411
Saudi ArabiaCohort 92411

Supporting publications

100 records
  1. 2026Exploring natural compounds and synthetic derivatives as potential inhibitors of SARS-CoV-2 PLpro: a computational approach with enzyme inhibition and cytotoxicity assessment.Journal of biomolecular structure & dynamics1 mentions
  2. 2026Protracted SARS-CoV-2 Infection in B-cell Depleted Patients: Immunologic and Viral Characteristics and Response to Dual and Extended Antiviral Therapy.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America1 mentions
  3. 2026IFNAR2 p.F8S Variant Associates with Severe COVID-19 and Adaptive Immune Cell Activation Modulation.International journal of molecular sciences1 mentions
  4. 2026Fundamental concepts of convergent (parallel) evolution in human-pathogenic viruses and their implications for global health.Virology1 mentions
  5. 2026Clinical Outcomes with the Use of Dipeptidyl Peptidase-4 (DPP-4) Inhibitor Among Patients with Diabetes Mellitus and COVID-19: A Systematic Review of Observational Studies.Journal of clinical medicine1 mentions
  6. 2026Vaccine effectiveness across the Omicron evolutionary spectrum (BA.2, BA.5, XBB, JN.1, KP.3): a systematic review of studies published 2022-2025.BMC infectious diseases1 mentions
  7. 2026Targeting SARS-CoV-2 main protease (3CLpro) with Paeonia-derived phytochemicals.In silico pharmacology1 mentions
  8. 2026Biochemical insights and microRNA profiling via next-generation sequencing in moderate and severe COVID-19 cases.Clinics (Sao Paulo, Brazil)1 mentions
  9. 2026Gold nanoparticles as dual-action antiviral agents: disruption of SARS-CoV-2 viral envelopes and RNA integrity.Scientific reports1 mentions
  10. 2025Molecular dynamic analyses of the interaction of SARS-CoV-1 or 2 variants with various angiotensin-converting enzyme-2 species.Journal of biomolecular structure & dynamics1 mentions
  11. 2025Clinical and epidemiological characteristics of respiratory syncytial virus, SARS-CoV-2 and influenza paediatric viral respiratory infections in southwest Saudi Arabia.Annals of medicine1 mentions
  12. 2025Uncovering Antiviral Potential of Cistus Ladanifer Extracts Against Herpes Simplex Virus 1 and Severe Acute Respiratory Syndrome Coronavirus 2 by In Vitro and In Silico Analysis.Chemistry & biodiversity1 mentions
  13. 2025In-Utero Maternal-to-Fetal Transmission of COVID-19: An Immunological and Virological Study in the Eastern Province of Saudi Arabia.Infection and drug resistance1 mentions
  14. 2025Silaproline-bearing nirmatrelvir derivatives are potent inhibitors of the SARS-CoV-2 main protease highlighting the value of silicon-derivatives in structure-activity-relationship studies.European journal of medicinal chemistry1 mentions
  15. 2025Innate immunity, therapeutic targets and monoclonal antibodies in SARS-CoV-2 infection.PeerJ1 mentions
  16. 2025First-in-class inhibitors of Nsp15 endoribonuclease of SARS-CoV-2: Modeling, synthesis, and enzymatic assay of thiazolidinedione and rhodanine analogs.The Journal of biological chemistry1 mentions
  17. 2025Immune transcriptomic analysis on COVID-19 patients with varying clinical presentations identifies severity markers.Scientific reports1 mentions
  18. 2025Fatty Acids and Inflammatory Protein Biomarkers From Coronavirus Disease 2019 Patients.Immunity, inflammation and disease1 mentions
  19. 2025Impact of COVID-19 vaccination on cancer patients: safety, efficacy, and long-term effects.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer1 mentions
  20. 2025New Neonatal and Prenatal Approach to Home Therapy with Amoxicillin, Rifaximin, and Anti-Inflammatory Drugs for Pregnant Women with COVID-19 Infections-Monitoring of Fetal Growth as a Prognostic Factor: A Triple Case Series (N.A.T.H.A.N.).Biomedicines1 mentions
  21. 2025Multisystem inflammatory syndrome in children (MIS-C) presenting with valvulitis, myocarditis, and QTc prolongation: A case report from Saudi Arabia.Medicine1 mentions
  22. 2025Immuno-epigenetic paradigms in coronavirus infection.Frontiers in immunology1 mentions
  23. 2025An exploratory binding study of molnupiravir efficacy against emerging Omicron SARS-CoV-2 variants.Scientific reports1 mentions
  24. 2025Cross-national disparities in healthcare workers' perceptions: Examining fear of infection and confidence in the received COVID-19 vaccines amid emerging variants.PloS one1 mentions
  25. 2025COVID-19 vaccine-induced autoimmune hyperthyroidism: Graves' disease.Frontiers in immunology1 mentions
  26. 2025Potential relationships between circulating gene expression of ACE2, TLR4, and IL-17 and disease severity and outcome of hospitalized patients with COVID-19.Journal of Zhejiang University. Science. B1 mentions
  27. 2024Structural basis for the mechanism of interaction of SARS-CoV-2 B.1.640.2 variant RBD with the host receptors hACE2 and GRP78.Journal of biomolecular structure & dynamics1 mentions
  28. 2024Impact of Respiratory Viruses and SARS-CoV-2 on Febrile Seizures in Saudi Children: Insights into Etiologies, Gender, and Familial Associations.Medical science monitor : international medical journal of experimental and clinical research1 mentions
  29. 2024SARS-CoV-2 NSP14 governs mutational instability and assists in making new SARS-CoV-2 variants.Computers in biology and medicine1 mentions
  30. 2024Molecular docking as a tool for the discovery of novel insight about the role of acid sphingomyelinase inhibitors in SARS- CoV-2 infectivity.BMC public health1 mentions
  31. 2024ACE2-Fc and DPP4-Fc decoy receptors against SARS-CoV-2 and MERS-CoV variants: a quick therapeutic option for current and future coronaviruses outbreaks.Antibody therapeutics1 mentions
  32. 2024Fusing Peptide Epitopes for Advanced Multiplex Serological Testing for SARS-CoV-2 Antibody Detection.ACS bio & med chem Au1 mentions
  33. 2024Utilizing sinapic acid as an inhibitory antiviral agent against MERS-CoV PLpro.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society1 mentions
  34. 2024Potential use of proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition and prevention method in viral infection.Microbial cell factories1 mentions
  35. 2024The global impact of SARS-CoV-2 variant BA.2.86: a comprehensive analysis with the latest developments and transmission trends - an epidemiological study.European review for medical and pharmacological sciences1 mentions
  36. 2024Assessment and classification of COVID-19 DNA sequence using pairwise features concatenation from multi-transformer and deep features with machine learning models.SLAS technology1 mentions
  37. 2024Pathogenesis of COVID19 and the applications of US FDA-approved repurposed antiviral drugs to combat SARS-CoV-2 in Saudi Arabia: A recent update by review of literature.Saudi journal of biological sciences1 mentions
  38. 2024Whole-Exome Sequencing Detecting a Recurrent Pathogenic Mutation, HFE p.His63Asp (H63D) in COVID-19 Patients and Its Effect on Mortality.Discovery medicine1 mentions
  39. 2024Circulation of Non-Middle East Respiratory Syndrome (MERS) Coronaviruses in Imported Camels in Saudi Arabia.Cureus1 mentions
  40. 2024Assessing the impact of severe acute respiratory syndrome coronavirus 2 infection on hematological parameters.Transactions of the Royal Society of Tropical Medicine and Hygiene1 mentions
  41. 2024Genetic risk factors for COVID-19 and influenza are largely distinct.Nature genetics1 mentions
  42. 2024Spectrum of respiratory viruses identified from SARS-CoV-2-negative human respiratory tract specimens in Watansoppeng, Indonesia.Access microbiology1 mentions
  43. 2024A review of the role of graphene-based nanomaterials in tackling challenges posed by the COVID-19 pandemic.Microbial pathogenesis1 mentions
  44. 2024Interleukin-1 Beta rs16944 and rs1143634 and Interleukin-6 Receptor rs12083537 Single Nucleotide Polymorphisms as Potential Predictors of COVID-19 Severity.Pathogens (Basel, Switzerland)1 mentions
  45. 2024Inactivation of Pseudovirus Expressing the D614G Spike Protein Mutation using Nitric Oxide-Plasma Activated Water.Advanced science (Weinheim, Baden-Wurttemberg, Germany)1 mentions
  46. 2024Vesicular Stomatitis Virus as a Platform for Protease Activity Measurements.Current protocols1 mentions
  47. 2024Exploring advanced genomic and immunoinformatics techniques for identifying drug and vaccine targets against SARS-CoV-2.Journal, genetic engineering & biotechnology1 mentions
  48. 2023The relevant information about the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) using the five-question approach (when, where, what, why, and how) and its impact on the environment.Environmental science and pollution research international1 mentions
  49. 2023Reporting dinaciclib and theodrenaline as a multitargeted inhibitor against SARS-CoV-2: an in-silico study.Journal of biomolecular structure & dynamics1 mentions
  50. 2023Mechanistic Insight and Possible Mechanism of Seizure in Covid-19: The Nuances and Focal Points.CNS & neurological disorders drug targets1 mentions
  51. 2023Monoclonal antibody designed for SARS-nCoV-2 spike protein of receptor binding domain on antigenic targeted epitopes for inhibition to prevent viral entry.Molecular diversity1 mentions
  52. 2023Unveiling the multitargeted potential of N-(4-Aminobutanoyl)-S-(4-methoxybenzyl)-L-cysteinylglycine (NSL-CG) against SARS CoV-2: a virtual screening and molecular dynamics simulation study.Journal of biomolecular structure & dynamics1 mentions
  53. 2023PheroxyPyrabenz and Carbopyrropyridin against major proteins of SARS CoV-2: a comprehensive in-silico molecular docking and dynamics simulation studies.Journal of biomolecular structure & dynamics1 mentions
  54. 2023Global emerging Omicron variant of SARS-CoV-2: Impacts, challenges and strategies.Journal of infection and public health1 mentions
  55. 2023Analysis of SARS-CoV-2 genomic surveillance data during the Delta and Omicron waves at a Saudi tertiary referral hospital.Journal of infection and public health1 mentions
  56. 2023Dysrhythmias associated with COVID-19: Review and management considerations.The American journal of emergency medicine1 mentions
  57. 2023Advanced Plasmonic Nanoparticle-Based Techniques for the Prevention, Detection, and Treatment of Current COVID-19.Plasmonics (Norwell, Mass.)1 mentions
  58. 2023COVID-19: A state of art on immunological responses, mutations, and treatment modalities in riposte.Journal of infection and public health1 mentions
  59. 2023Safety, Tolerability and Pharmacokinetics of Half-Life Extended Severe Acute Respiratory Syndrome Coronavirus 2 Neutralizing Monoclonal Antibodies AZD7442 (Tixagevimab-Cilgavimab) in Healthy Adults.The Journal of infectious diseases1 mentions
  60. 2023Assessment of the Prevalence and Incidence of COVID-19 in Saudi Arabia.Journal of multidisciplinary healthcare1 mentions
  61. 2023Whale optimization with random contraction and Rosenbrock method for COVID-19 disease prediction.Biomedical signal processing and control1 mentions
  62. 2023In silico prediction of potential inhibitors for SARS-CoV-2 Omicron variant using molecular docking and dynamics simulation-based drug repurposing.Journal of molecular modeling1 mentions
  63. 2023Molecular evolutionary model based on phylogenetic and mutation analysis of SARS-CoV-2 spike protein sequences from Asian countries: A phylogenomic approach.Informatics in medicine unlocked1 mentions
  64. 2023Artificial Intelligence: A Next-Level Approach in Confronting the COVID-19 Pandemic.Healthcare (Basel, Switzerland)1 mentions
  65. 2023The potential role of SARS-CoV-2 infection in acute coronary syndrome and type 2 myocardial infarction (T2MI): Intertwining spread.Immunity, inflammation and disease1 mentions
  66. 2023SARS-CoV-2 Detection and COVID-19 Diagnosis: A Bird's Eye View.Reviews on recent clinical trials1 mentions
  67. 2023SARS-CoV-2 Outbreak Investigation Using Contact Tracing and Whole-Genome Sequencing in an Ontario Tertiary Care Hospital.Microbiology spectrum1 mentions
  68. 2023The potential role of scavenger receptor B type I (SR-BI) in SARS-CoV-2 infection.Immunity, inflammation and disease1 mentions
  69. 2023CRISPR-Cas13a-powered electrochemical biosensor for the detection of the L452R mutation in clinical samples of SARS-CoV-2 variants.Journal of nanobiotechnology1 mentions
  70. 2023Clinical features of Omicron variant infection in 445 patients with coronavirus 19 disease.Annals of Saudi medicine1 mentions
  71. 2023Discovering common pathogenic processes between COVID-19 and HFRS by integrating RNA-seq differential expression analysis with machine learning.Frontiers in microbiology1 mentions
  72. 2023The effects of prolactin on the immune system, its relationship with the severity of COVID-19, and its potential immunomodulatory therapeutic effect.Cytokine1 mentions
  73. 2023Genome-wide epistasis study highlights genetic interactions influencing severity of COVID-19.European journal of epidemiology1 mentions
  74. 2023Viruses and autism: A Bi-mutual cause and effect.World journal of virology1 mentions
  75. 2023T cell receptor β repertoires in patients with COVID-19 reveal disease severity signatures.Frontiers in immunology1 mentions
  76. 2023Preoperative universal screening of coronavirus disease 2019 during Omicron outbreak in patients undergoing ophthalmic surgeries: Experience from a tertiary eye care center in Saudi Arabia.Saudi journal of ophthalmology : official journal of the Saudi Ophthalmological Society1 mentions
  77. 2023The Effect of COVID-19 Vaccines on Hospital Admission and Severity of Symptoms Among COVID-19 Patients in Saudi Arabia, 2021.Cureus1 mentions
  78. 2023Coronavirus and co-infections: A Saudi Arabian perspective.Saudi journal of biological sciences1 mentions
  79. 2023Early and Sensitive Detection of Pathogens for Public Health and Biosafety: An Example of Surveillance and Genotyping of SARS-CoV-2 in Sewage Water by Cas12a-Facilitated Portable Plasmonic Biosensor.Research (Washington, D.C.)1 mentions
  80. 2023Natural Killer Cells in SARS-CoV-2-Vaccinated Subjects with Increased Effector Cytotoxic CD56dim Cells and Memory-Like CD57+NKG2C+CD56dim Cells.Frontiers in bioscience (Landmark edition)1 mentions
  81. 2023Repurposing the oncolytic virus VSV∆51M as a COVID-19 vaccine.Frontiers in bioengineering and biotechnology1 mentions
  82. 2023SARS-CoV-2 infections and MIS-C among children: A narrative review.Medicine1 mentions
  83. 2023Severity of SARS-CoV-2 infection in children with inborn errors of immunity (primary immunodeficiencies): a systematic review.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology1 mentions
  84. 2023Development of Rapid Aptamer-Based Screening Assay for the Detection of Covid-19 Variants.ACS omega1 mentions
  85. 2023Design and Assessment of a Novel In Silico Approach for Developing a Next-Generation Multi-Epitope Universal Vaccine Targeting Coronaviruses.Microorganisms1 mentions
  86. 2023Insights on Covid-19 with superimposed pulmonary histoplasmosis: The possible nexus.Immunity, inflammation and disease1 mentions
  87. 2023Intrinsic factors behind long-COVID: II. SARS-CoV-2, extracellular vesicles, and neurological disorders.Journal of cellular biochemistry1 mentions
  88. 2023Incompetent memory immune response in severe COVID-19 patients under treatment.Heliyon1 mentions
  89. 2023Omicron new variant BA.2.86 (Pirola): Epidemiological, biological, and clinical characteristics - a global data-based analysis.European review for medical and pharmacological sciences1 mentions
  90. 2023Evaluation of Potential Peptide-Based Inhibitors against SARS-CoV-2 and Variants of Concern.BioMed research international1 mentions
  91. 2023Blood coagulation, risk factors and associated complications in COVID-19 patients in Saudi Arabia: A retrospective cohort study.Medicine1 mentions
  92. 2023Effectiveness of COVID-19 vaccines against ICU admission during Omicron surge in Saudi Arabia: a nationwide retrospective cohort study.BMC infectious diseases1 mentions
  93. 2023Efficacy of Oxford-AstraZeneca (ChAdOx1 CoV-19) vaccine against Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) cases, hospital admissions, type of variants, and deaths.European review for medical and pharmacological sciences1 mentions
  94. 2023Non-synonymous Single Nucleotide Polymorphisms in Human ACE2 Gene May Affect the Infectivity of SARS-CoV-2 Omicron Subvariants.Current pharmaceutical design1 mentions
  95. 2023Navigating Vaccine Uncertainty: Anxiety and Fourth Dose Hesitancy Among Saudi Adults.Cureus1 mentions
  96. 2023Mutational analysis of SARS-CoV-2 ORF6-KPNA2 binding interface and identification of potent small molecule inhibitors to recuse the host immune system.Frontiers in immunology1 mentions
  97. 2023Elucidating the binding mechanism of SARS-CoV-2 NSP6-TBK1 and structure-based designing of phytocompounds inhibitors for instigating the host immune response.Frontiers in chemistry1 mentions
  98. 2022Effect of mutation and vaccination on spread, severity, and mortality of COVID-19 disease.Journal of medical virology1 mentions
  99. 2022Analyzing the effect of mutations in SARS-CoV2 papain-like protease from Saudi isolates on protein structure and drug-protein binding: Molecular modelling and dynamics studies.Saudi journal of biological sciences1 mentions
  100. 2022Periodically aperiodic pattern of SARS-CoV-2 mutations underpins the uncertainty of its origin and evolution.Environmental research1 mentions